Form 4 for CNS COHEN & STEERS, INC.
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-16 · accession 0001284812-23-000112 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-17 | 2023-03-16 | CNS | Harvey Joseph M | CEO, Pres, Dir | A - Grant | $0.00 | +1,268 | 1.29M | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-16 | A | A | 1,268 | $0.00 | 1,290,597 | D | — | — | (F2) Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2023 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2020, January 2021, January 2022 and January 2023. |